Dr. Cornblath is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 N. Caroline St.
Baltimore, MD 21287Phone+1 410-955-2229- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemResidency, Neurology, 1978 - 1982
- Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 1977 - 1978
- Case Western Reserve University School of MedicineClass of 1977
Certifications & Licensure
- NJ State Medical License 1982 - Present
- MD State Medical License 1982 - 2022
- FL State Medical License 2016 - 2018
- PA State Medical License 1980 - 1984
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Top Doctors:Baltimore Area Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD) Start of enrollment: 2012 Nov 01
Publications & Presentations
PubMed
- 8 citationsEuropean Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.Pieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, Bert Avau, Patrik Vankrunkelsven, Shahram Attarian, Patricia H Blomkwist-Markens, David R Cornblath, H ...> ;Journal of the Peripheral Nervous System. 2023 Dec 1
- European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.Pieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, Bert Avau, Patrik Vankrunkelsven, Shahram Attarian, Patricia H Blomkwist-Markens, David R Cornblath, H ...> ;European Journal of Neurology. 2023 Dec 1
- Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis.Mark T Brown, David R Cornblath, Martin Koltzenburg, Kenneth C Gorson, Anne Hickman, Glenn C Pixton, Puneet Gaitonde, Lars Viktrup, Christine R West> ;Clinical Drug Investigation. 2023 Jul 1
- Join now to see all
Journal Articles
- Regional Variation of Guillain-Barré SyndromeDavid Cornblath, MD, Brain
Press Mentions
- A Cross-Sectional Study of Ocular Surface Discomfort and Corneal Nerve Dysfunction After Paclitaxel Treatment for CancerJanuary 19th, 2021
- Intravenous Immunoglobulin Is Safe and Effective as Maintenance Therapy for Patients with Chronic Inflammatory Demyelinating PolyneuropathyOctober 12th, 2020
- Präsentation Der Endgültigen Ergebnisse Aus Der ProCID-Studie Zur Wirksamkeit Und Sicherheit Dreier Unterschiedlicher Dosierungen Von Panzyga® (NewGam) Bei Patienten Mit Chronischer Entzündlicher Demyelinisierender Polyneuropathie (CIDP) Auf Der...May 18th, 2020
- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/david-cornblath
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: